Medical countermeasures to WMDs: Defence research for civilian and military use

Toxicology

Volumn 233, Issue 1-3 SPEC. ISS., 2007, Pages 8-12

  Hamilton, Murray G ^a   Lundy, Paul M ^b  

^a UNIVERSITY OF DENVER   (United States)

^b Therapeutic Response Ltd   (Canada)

Author keywords

Chemical warfare; Civilian applications; Defense research; Nerve agents; Sulfur mustard; Vesicants

Indexed keywords

1 (3 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; 1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ACETYLCHOLINESTERASE; ATROPINE; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CHEMICAL WARFARE AGENT; CHLORINE; CHOLINESTERASE; DIAZEPAM; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; MUSTARD GAS; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERVE GAS; OBIDOXIME; PHOSGENE; PRALIDOXIME; PRALIDOXIME MESILATE; PYRIDOSTIGMINE; SARIN; SAXITOXIN; SCOPOLAMINE; SOMAN; TABUN;

ABSENCE OF SIDE EFFECTS; ARTICLE; CHEMICAL WARFARE; CONVULSION; DRUG EFFICACY; DRUG INDICATION; HUMAN; INTOXICATION; LD 50; LETHALITY; MEDICAL RESEARCH; MILITARY MEDICINE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTECTIVE CLOTHING;

BIOMEDICAL RESEARCH; CHEMICAL WARFARE; CHEMICAL WARFARE AGENTS; DISASTER PLANNING; EMERGENCY MEDICAL SERVICES; MILITARY MEDICINE; POISONING;

EID: 33947709527     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.08.034     Document Type: Article

References (16)

1. Bhagat Y.A., Obenaus A., Hamilton M.G., Mikler J., and Kendall EJ. Neuroprotection from soman-induced seizures in the rodent: evaluation with diffusion- and T2-weighted magnetic resonance imaging. Neurotoxicology 26 (2005) 1001-1013
2. Broomfield C.A., Maxwell D.M., Solana R.P., Castro C.A., Finger A.V., and Lenz D.E. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. Pharmacol. Exp. Ther. 259 (1991) 633-638
3. de Groot D.M., Bierman E.P., Bruijnzeel P.L., Carpentier P., Kulig B.M., Lallement G., Melchers B.P., Philippens I.H., and van Huygevoort A.H. Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour. J. Appl. Toxicol. 21 Suppl. 1 (2001) S57-S65
4. Falahati, F., Soroush, M.R., Salamat, A., A., Khateri, S., Hosseini, A.R., 2004. A 20 year cancer related mortality follow-up study of mustard gas exposed Iranian veterans. ASA Newsletter 04-4, 1.
5. Keeler J.R., Hurst C.G., and Dunn M.A. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA 266 5 (1991) 693-695
6. Langermann, S., 2006, Protexia. Chem. Biol. Med. Treat. Symp. VI, Spiez.
7. Leadbeater L., Inns R.H., and Rylands JM. Treatment of poisoning by soman. Fundam. Appl. Toxicol. 5 (1985) S225-S231
8. Lenz D., Maxwell D., Koplovitz I., Clark C., Capacio B., Cerasoli D., Federko J., Luo C., Saxena A., Doctor B., and Olson C. Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys. Chem. Biol. Interact. 157-158 (2005) 205-210
9. Lipton S. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Drug Discov. 5 (2006) 160-170
10. Lundy P.M., Sawyer T.W., Hand B.T., and Frew R. Effects of bis (2-chloroethyl)sulfide on ATP receptor-mediated responses of the rat vas deferens: possible relationship to cytotoxicity. J. Pharmacol. Exp. Ther. 285 (1998) 299-306
11. Maxwell D.M., Castro C.A., De La Hoz D.M., Gentry M.K., Gold M.B., Solana R.P., Wolfe A.D., and Doctor B.P. Protection of rhesus monkeys against soman and prevention of performance decrement by pretreatment with acetylcholinesterase. Toxicol. Appl. Pharmacol. 115 (1992) 44-49
12. Meshulam Y., Cohen G., Chapman S., Alkalai D., and Levy A. Prophylaxis against organophosphate poisoning by sustained release of scopolamine and physostigmine. J. Appl. Toxicol. 21 Suppl. 1 (2001) S75-S78
13. Moore G.J., Moore D.M., Roy S.S., Hayden L.J., and Hamilton. M.G., Chan, N.W., Lee, W.E. Hinge peptide combinatorial libraries inhibitors of botulinum neurotoxins and saxitoxin: deconvolution strategy. Mol. Divers 10 1 (2006) 9-16
14. Muggleton N.G., Bowditch A.P., Crofts H.S., Scott E.A., and Pearce P.C. Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus). Psychopharmacology (Berlin) 166 3 (2003) 212-220
15. Wilson I.B., and Ginsberg S. A powerful reactivator of alkyl phosphate-inhibited acetylcholinesterase. Biochim. biophys. Acta. 18 (1955) 168-170
16. Wolfe A.D., Blick D.W., Murphy M.R., Miller S.A., Gentry M.K., Hartgraves S.L., and Doctor B.P. Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. Toxicol. Appl. Pharmacol. 117 (1992) 189-193